- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- monomer
- Ligands
- 2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x 95T: 5-(4-chlorophenyl)-~{N}-(3,5-dimethoxyphenyl)furan-2-carboxamide(Non-covalent)
- 4 x CLR: CHOLESTEROL(Non-covalent)
CLR.7: 5 residues within 4Å:- Chain A: T.679, L.766, S.769, W.770, I.1290
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:T.679, A:L.766, A:W.770, A:W.770, A:I.1290
CLR.18: 3 residues within 4Å:- Chain A: T.1215, A.1217, W.1220
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:A.1217, A:W.1220, A:W.1220
CLR.23: 4 residues within 4Å:- Chain A: S.341, F.342, M.1494, V.1495
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:F.342, A:V.1495
CLR.27: 13 residues within 4Å:- Chain A: L.393, T.397, E.401, I.886, L.889, V.1414, I.1418, M.1713, V.1714, Y.1717, I.1718, I.1721, F.1725
11 PLIP interactions:11 interactions with chain A- Hydrophobic interactions: A:L.393, A:T.397, A:I.886, A:L.889, A:V.1414, A:I.1418, A:V.1714, A:Y.1717, A:Y.1717, A:I.1718, A:F.1725
- 5 x PCW: 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)(Non-functional Binders)
PCW.8: 15 residues within 4Å:- Chain A: F.260, F.382, G.1450, G.1538, W.1539, F.1542, I.1587, R.1594, T.1595, L.1597, F.1598, M.1601, L.1604, V.1727
- Ligands: PCW.9
8 PLIP interactions:8 interactions with chain A- Hydrophobic interactions: A:F.260, A:F.382, A:W.1539, A:W.1539, A:F.1542, A:I.1587, A:L.1604
- Salt bridges: A:R.1594
PCW.9: 11 residues within 4Å:- Chain A: K.1452, T.1536, N.1537, G.1538, F.1542, L.1577, M.1601
- Ligands: PCW.8, LPE.11, PCW.12, LPE.14
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:F.1542
- Hydrogen bonds: A:G.1538
- Salt bridges: A:K.1452
PCW.12: 1 residues within 4Å:- Ligands: PCW.9
No protein-ligand interaction detected (PLIP)PCW.15: 11 residues within 4Å:- Chain A: K.728, W.729, F.732, F.764, I.777, G.781, F.1295, I.1400, F.1404
- Ligands: LPE.13, PCW.16
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:W.729, A:F.764, A:F.1295, A:I.1400, A:F.1404, A:F.1404
- Salt bridges: A:K.728
PCW.16: 7 residues within 4Å:- Chain A: V.754, M.1298, Y.1393, M.1394, Y.1397, I.1400
- Ligands: PCW.15
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:V.754, A:Y.1397, A:I.1400
- 9 x LPE: 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)(Non-functional Binders)
LPE.10: 7 residues within 4Å:- Chain A: Q.1439, Y.1442, P.1605, L.1607, F.1608, G.1611, M.1716
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:Q.1439
LPE.11: 2 residues within 4Å:- Chain A: L.1449
- Ligands: PCW.9
No protein-ligand interaction detected (PLIP)LPE.13: 16 residues within 4Å:- Chain A: I.780, S.783, V.784, T.791, L.794, F.843, L.846, V.881, L.884, F.1366, I.1402, I.1403, F.1404, F.1407, F.1408
- Ligands: PCW.15
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:V.784, A:T.791, A:I.1403, A:F.1404, A:F.1404, A:F.1408
- Hydrogen bonds: A:I.1403
LPE.14: 9 residues within 4Å:- Chain A: Y.373, F.376, L.379, F.1567, S.1568, T.1570, L.1571, V.1574
- Ligands: PCW.9
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:F.376, A:L.379
LPE.17: 3 residues within 4Å:- Chain A: N.1216, A.1217, W.1218
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:A.1217, A:W.1218, A:W.1218
- Hydrogen bonds: A:A.1217
LPE.19: 8 residues within 4Å:- Chain A: S.1166, G.1167, A.1170, F.1171, F.1615, L.1616, F.1619, F.1647
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:L.1616, A:F.1619
LPE.20: 1 residues within 4Å:- Ligands: P5S.24
No protein-ligand interaction detected (PLIP)LPE.21: 2 residues within 4Å:- Chain A: M.684
- Ligands: LPE.22
No protein-ligand interaction detected (PLIP)LPE.22: 5 residues within 4Å:- Chain A: I.680, S.690, T.692, M.696
- Ligands: LPE.21
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:I.680
- Hydrogen bonds: A:T.692
- 3 x P5S: O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine(Non-covalent)
P5S.24: 16 residues within 4Å:- Chain A: L.1285, C.1288, L.1289, W.1292, N.1352, A.1354, M.1355, L.1361, P.1695, A.1696, I.1699, I.1700, T.1703, T.1704, I.1707
- Ligands: LPE.20
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:L.1285, A:L.1289, A:W.1292, A:L.1361, A:I.1699, A:I.1700, A:T.1704, A:I.1707
- Hydrogen bonds: A:N.1352
P5S.25: 5 residues within 4Å:- Chain A: F.1468, I.1472, R.1475, F.1478, M.1525
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:F.1468, A:I.1472, A:F.1478
- Hydrogen bonds: A:R.1475
- Salt bridges: A:R.1475
P5S.26: 8 residues within 4Å:- Chain A: Y.336, W.344, F.350, K.863, S.864, L.867, L.871, T.872
8 PLIP interactions:8 interactions with chain A- Hydrophobic interactions: A:F.350, A:L.867, A:L.871, A:L.871, A:L.871, A:T.872
- Salt bridges: A:K.863, A:K.863
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Huang, X. et al., Structural basis for high-voltage activation and subtype-specific inhibition of human Na v 1.8. Proc.Natl.Acad.Sci.USA (2022)
- Release Date
- 2022-08-03
- Peptides
- Sodium channel protein type 10 subunit alpha: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- monomer
- Ligands
- 2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x 95T: 5-(4-chlorophenyl)-~{N}-(3,5-dimethoxyphenyl)furan-2-carboxamide(Non-covalent)
- 4 x CLR: CHOLESTEROL(Non-covalent)
- 5 x PCW: 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)(Non-functional Binders)
- 9 x LPE: 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)(Non-functional Binders)
- 3 x P5S: O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Huang, X. et al., Structural basis for high-voltage activation and subtype-specific inhibition of human Na v 1.8. Proc.Natl.Acad.Sci.USA (2022)
- Release Date
- 2022-08-03
- Peptides
- Sodium channel protein type 10 subunit alpha: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A - Membrane
-
We predict this structure to be a membrane protein.